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Acceptance and Commitment Therapy as a Treatment for Scrupulosity in Obsessive Compulsive Disorder
John P. Dehlin 1, Kate L. Morrison 1, and Michael P. Twohig 1
Abstract
This study evaluated acceptance and commitment therapy (ACT) for scrupulosity-based obsessive
compulsive disorder (OCD). Five adults were treated with eight sessions of ACT, without in-session
exposure, in a multiple baseline across participants design. Daily monitoring of compulsions and avoided
valued activities were tracked throughout the study. The Obsessive Compulsive Inventory–Revised,
Yale–Brown Obsessive Compulsive Scale (Y-BOCS), Penn Inventory of Scrupulosity, Beck Depression
Inventory–II, Quality of Life Scale, Santa Clara Strength of Religious Faith Questionnaire, and the
Acceptance and Action Questionnaire–II were completed at pretreatment, posttreatment, and 3-month
follow-up. The Treatment Evaluation Inventory was completed at posttreatment. Average daily
compulsions reduced as follows: pretreatment = 25.0, posttreatment = 5.6, and follow-up = 4.3. Average
daily avoided valued activities reduced as follows: pretreatment = 6.0, posttreatment = 0.7, and followup = 0.5. Other measures showed similar patterns. Religious faith only slightly declined: 4% at
posttreatment and 7% at follow-up. Treatment acceptability was high.
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Scrupulosity is a distressing form of obsessive compulsive disorder (OCD) characterized by unreasonable,
egodystonic, anxiety-producing intrusive thoughts about religious or moral issues, accompanied by
compulsive thoughts or behaviors performed with the intent of neutralizing anxiety (Abramowitz,
Huppert, Cohen, Tolin, & Cahill, 2002; Ciarrocchi, 1995). Four of the most common, general
manifestations of scrupulosity include (a) compulsive behaviors that far exceed religious norms or
requirements (e.g., praying for hours a day), (b) narrowly focused compulsions (e.g., avoiding the risk of
an inappropriate sexual thought at the expense of fulfilling other religious duties), (c) excessive focus on
religious trivialities (e.g., compulsions to avoid spilling a drop of holy water), and (d) a tendency to
misconstrue, and/or overly literalize scriptural passages (Cefalu, 2010).
Scrupulosity is estimated to occur in 5% to 33% of OCD patients, or 0.05% to 0.33% of the general
population (Miller & Hedges, 2008). Although scrupulosity has reasonably high levels of prevalence and
clinical distress (Cefalu, 2010; Fallon, Liebowitz, Hollander, & Schneier, 1990), it has received minimal
attention from researchers in terms of its etiology and treatment (Miller & Hedges, 2008). At present,
the first-line treatment for OCD is cognitive-behavior therapy using exposure and response prevention
(ERP) or serotonergenic medications (Abramowitz, 2008). It should be noted that these findings are from
larger treatment trials for OCD and not from scrupulosity trials specifically. One small (N = 10) study on
scrupulosity has been conducted to date (Fallon et al., 1990), wherein 5 of 10 patients were rated as

much improved after 8 weeks of treatment with fluoxetine, with 1 additional participant responding to
adjunctive clomipramine. A handful of case studies have been published on the treatment of
scrupulosity with ERP as well, though few are conclusive (Abramowitz, 2001; Bonchek & Greenberg,
2009; Garcia, 2008; Greenberg & Witztum, 2001; Huppert & Siev, 2010). In one case citing outcome
data, Abramowitz (2001) found a posttreament reduction of 65% in Yale–Brown Obsessive Compulsive
Scale (Y-BOCS; Goodman, Price, Rasmussen, & Mazure, 1989a, 1989b) scores, along with a reduction in
Beck Depression Inventory (BDI) scores from 28 at intake to 10 at posttreatment. Finally, no known
clinical psychology trials for scrupulosity have been conducted to date, suggesting room for additional
scrupulosity research.
Acceptance and commitment therapy (ACT) for OCD is a form of cognitive-behavioral therapy that holds
promise for scrupulosity-based OCD (Twohig, 2009). ACT for OCD seeks to address the context in which
obsessions are experienced through the teaching and practice of such concepts as acceptance of
thoughts and feelings, learning to disempower thoughts and feelings by not giving them more
significance than they merit, mindfulness, and values-based committed action. These skills are taught
through exercises, discussions, and experiential exercises and metaphors in the therapy sessions.
Through weekly homework assignments, clients are able to further apply the techniques learned in
session to real-life situations and problems.
ACT has been shown to be a viable treatment for OCD in at least two studies (Twohig et al., 2010;
Twohig, Hayes, & Masuda, 2006). In these studies, ERP or similar practices were not used so that the
effects of ACT could be determined without the influence of already supported procedures. If ACT was
first tested with exposure exercises, it would have been difficult to determine what components were
producing the outcomes. Because the effects of ACT alone have been demonstrated, other studies have
been testing the effects of combining ACT and traditional exposure exercises (e.g., Meuret, Twohig,
Hayes, Rosenfield, & Craske, 2012).
In a multiple baseline across participants design using ACT for OCD (Twohig et al., 2006), significant
reductions in compulsions were achieved by all participants with results maintained at 3-month followup. OCD symptom severity (as measured by the Obsessive Compulsive Inventory–Revised [OCI-R])
improved by 68% from pretreatment to posttreatment, and increased to 81% at follow-up. In a
randomized clinical trial for OCD (Twohig et al., 2010), eight sessions of ACT for OCD were compared
with a control treatment of Progressive Relaxation Training (PRT; N = 79). ACT demonstrated greater
positive change in OCD severity as measured by the Y-BOCS (ACT pre = 24.22, post = 12.76, follow-up =
11.79; PRT pre = 25.4, post = 18.67, follow-up = 16.23), and clinically significant change rates (Jacobson
& Truax, 1991) were also significantly in favor of ACT (ACT post = 46%-56%, follow-up = 46%-66%; PRT
post = 13%-18%, follow-up = 16%-18%). ACT demonstrated low treatment refusal (ACT = 2.4%, PRT =
7.8%) and drop-out (ACT = 9.8%, PRT = 13.2%) rates, and significantly greater treatment acceptability
than PRT (ACT = 4.38, PRT = 3.28 on a 5-point scale).
ACT appears to be an especially good fit for the treatment of scrupulosity-based OCD. Because ACT
targets the process of thinking, similar to other metacognitive therapies, ACT for scrupulosity-based OCD
can be successfully implemented without content knowledge of religious doctrine, and without
excessive attention given to “proper” religious practice. This can be useful because individuals with
scrupulosity-based OCD are often stuck in the details of religious doctrine or practice, usually to the
detriment of meaningful religious activity. ACT helps clients find ways to live regardless of their

obsessional concerns, and uses the metric of “meaningful activities” to track treatment success. Thus,
ACT for scrupulosity-based OCD largely sidesteps religious content and cognitions, and instead focuses
on how clients live their lives. It is through this process that clients may eventually learn ways to align
their personal values and religious practices in a way that is personally meaningful. Given the supportive
outcomes seen in ACT for OCD generally, the seemingly good fit for ACT, and the dearth of data on the
treatment of scrupulosity-based OCD, a preliminary test of ACT for scrupulosity-based OCD seems
warranted.
To provide initial data on the suitability of ACT for scrupulosity, this study used a multiple baseline
across participants design with five participants with scrupulosity-based OCD. The treatment was based
on ACT for OCD (Twohig et al., 2006; Twohig et al., 2010), and was tailored for scrupulosity-based OCD
specifically. Consistent with ACT’s focus on quality of life, the primary dependent variables for this study
were (a) the frequency of daily compulsions and (b) avoided valued activities, tracked by each
participant throughout the study. Self-report data were supported by standardized measures completed
at pretreatment, posttreatment, and 3-month follow-up. Psychological flexibility was measured
throughout treatment to track changes in ACT’s purported process of change. It is predicted that eight
sessions of ACT for OCD will result in visibly significant reductions in daily compulsions and avoided
valued activities for a majority of participants and that psychological flexibility will increase. It is
predicted that ACT for OCD will also result in lower scores on OCD, scrupulosity, and depression
measures, higher scores on quality-of-life measures, and no significant changes on religiosity measures.
Finally, it is predicted that participants will rate the treatment as acceptable.
Method
Participants
Participants for this study were recruited through advertisements in local newspapers, websites, radio,
flyers placed around the community, and through announcements made to undergraduate psychology
classes at a university in the western United States. Inclusion criteria for the study were as follows: (a)
above the age of 18, (b) a diagnosis of OCD based on the Structured Clinical Interview for DSM-IV (SCID;
First, Spitzer, Gibbon, & Williams, 2002), and (c) an initial Y-BOCS endorsement of scrupulosity-based
OCD. Exclusion criteria were the following: (a) non-English speaking, (b) a primary DSM-IV diagnosis
other than OCD, (c) current participation in psychotherapy elsewhere, or having received treatment
within the past 30 days, (d) any change in psychotropic prescription usage over the past 30 days, or a
plan to change current prescription levels over the course of treatment, or (e) any type of detectable
disability that would severely interfere with participation in the study. Eighteen participants were
formally screened for the study. Nine did not qualify either because they did not meet criteria for OCD,
or because their obsessions and compulsions were not religious in nature. Two qualified after the initial
screening but chose not to participate in the study due to either excessive travel requirements, or not
wanting to monitor their daily compulsions. Seven were accepted into the study and began baseline
tracking, and two dropped out of the study prior to beginning treatment (one due to not wanting to
continue tracking his compulsions and the other because his symptom severity improved to the point of
no longer desiring treatment). Table 1 details the primary participant characteristics of those who began
treatment.
Measures

Diagnostic Measures.
SCIDThe SCID (First et al., 2002) is a semistructured interview for making Diagnostic and Statistical
Manual of Mental Disorders (4th ed.; DSM-IV; American Psychiatric Association, 1994) Axis I diagnoses.
It is widely held as the gold standard for both psychological and psychiatric diagnosis, and has
demonstrated suitable reliability and validity in multiple studies (Segal, Hersen, & Van Hasselt, 1994).
Outcome Measures.
Self-monitoringCompulsions and avoided valued activities were operationally defined for each
participant, and these definitions were used to track the occurrence of these behaviors. Compulsions
were individually defined, and avoided valued activities were defined as valued activities that were
avoided because of fear that they might trigger the obsessions or compulsions (e.g., praying, going to
church or the temple). At the end of each day, participants were sent an email reminding them to enter
their data into a secure online web form. These data were the primary dependent variables for this
study, upon which treatment decisions were based. While specific reliability and validity statistics are
not available for this study, self-monitoring of specific behaviors, after appropriate training, has been
found to result in accurate assessment of behavior (Jackson, 1999; Korotitsch & Nelson-Gray, 1999).
OCI-RThe OCI-R (Foa et al., 2002) is an 18-item self-report measure of common OCD symptoms, wherein
respondents rate bother/distress on a scale of 0 to 4 (not at all to very much). The OCI-R assesses six
primary subdomains: (a) washing, (b) obsessing, (c) hoarding, (d) ordering, (e) checking, and (f)
neutralizing. Overall scores on the OCI-R range between 0 and 72, and subscale scores range between 0
and 12. The OCI-R possesses good psychometric properties (αs between .81 and .93) and adequate test–
retest reliability (.57-.91; Foa et al., 2002).
Penn Inventory of Scrupulosity (PIOS)The PIOS (Abramowitz et al., 2002) is a 19-item self-report
measure developed to assess scrupulosity in the context of OCD. The PIOS consists of two subscales: one
measuring the fear of having committed sin and another measuring fear concerning God’s punishment.
Items are rated on a 5-point scale ranging from 0 (never) to 4 (constantly). The PIOS has strong internal
consistency (α = .91) and appropriate convergent and discriminate validity (Abramowitz et al., 2002).
Yale–Brown Obsessive Compulsive Scale (Y-BOCS)The Y-BOCS (Goodman et al., 1989a, 1989b) is an
assessor-rated measure of OCD symptom severity with two subscales: obsession and compulsion. The
score for each subscale ranges from 0 to 20, with a total score range from 0 to 40. The Y-BOCS has
acceptable interrater reliability for the total score (between .80 and .97) and a 2-week test–retest
reliability of between .81 and .97.
BDI-IIThe BDI-II (Beck, 1996) is a 21-item measure of depression-related symptoms like sadness,
pessimism, loss of pleasure, suicidal thoughts, and so on. It has strong psychometric properties (Beck,
Epstein, Brown, & Steer, 1988), showing good internal consistency, high test−retest reliability (r = .93),
and a high correlation with the original BDI (r = .93; Beck, 1996).
Quality of Life Scale (QOLS)The QOLS (Burckhardt, Woods, Schultz, & Ziebarth, 1989) is a 16-question
assessment that measures overall life satisfaction. Items are rated on a 7-point scale ranging from 1 =
terrible to 7 = delighted. A minimum score for the assessment is 16 and a maximum score is 112, with
higher scores indicating better quality of life. The QOLS has been found to be internally consistent (α

between .89 and .92), with acceptable temporal stability (r between .78 and .84 over a 3-week period;
Burckhardt et al., 1989).
Santa Clara Strength of Religious Faith Questionnaire (SCSORF)The SCSORF (Plante & Boccaccini, 1997) is
a 10-item measure scored on a 4-point scale measuring strength of religious faith (e.g., “My religious
faith is extremely important to me.”). Answers range from 1 = strongly disagree to 4 = strongly agree.
Research has found coefficient alphas between .94 and .95 and split-half reliability between .90 and .96.
Due to clerical error, Questions 9 and 10 were omitted from this measure. Thus, results from this
measure should be viewed cautiously in this study.
Psychological Process Measure.
Acceptance and Action Questionnaire–II (AAQ-II)The AAQ-II (Bond et al., 2011) is a measure of
psychological flexibility. Seven questions are rated on a 7-point Likert-type scale, ranging from 1 = never
true to 7 = always true. Higher scores on the AAQ-II are reflective of greater experiential avoidance and
immobility, whereas lower scores reflect greater acceptance and action. The mean alpha coefficient for
the AAQ-II is .84, and the 3- and 12-month test–retest reliability is .81 and .79, respectively (Bond et al.,
2011).
Treatment Acceptability Measure.
Treatment Evaluation Inventory–Short Form (TEI-SF)The acceptability of this treatment was measured
with the TEI-SF (Kelley, Heffer, Gresham, & Elliott, 1989). Questions are rated on a 5-point Likert-type
scale ranging from “strongly disagree” to “strongly agree,” with some of the responses requiring
reverse-scoring. Two of the questions from the original TEI-SF were omitted, because they dealt
specifically with issues surrounding family interventions. Total scores on this version of the TEI-SF range
from a minimum of 5 to a maximum of 35. The TEI-SF has shown to be internally consistent (α = .85).
Reliability Checks for SCID and Y-BOCS
All assessment sessions were video recorded. A trained graduate student viewed and scored 20% of the
Y-BOCS and 20% of the SCID assessments for interrater reliability. Checking for interrater reliability
involved viewing the sections of video where the SCID and Y-BOCS occurred and completing these
measures without knowledge of previous scores. Each item on the Y-BOCS was compared, and the
presence or absence of diagnosis was compared for the SCID. There was 97% agreement on the Y-BOCS
(with the one disagreement having a 2-point difference). The assessor score was retained. There was
100% agreement on the scoring of the SCID. It should be noted that these were not independently
conducted assessments but that the second assessor had to complete the assessments based off the
primary assessor’s questioning.
Procedure
A multiple baseline across participants design was used in this study. The primary dependent variables
tracked for each participant throughout the entire study (pretreatment, posttreatment, and follow-up)
were the frequency of compulsions, along with a measure of avoided valued activities. These data were
collected daily by the participants, and reported via a secure Internet web form on a daily basis. To
begin, a single participant was selected to start tracking daily compulsions and avoided valued activities.
After baseline was established, treatment commenced. The following four participants started

treatment after baseline durations that were longer than the previous participant. Thus, in this
particular study, Participants 4 and 5 served as controls for Participants 1 to 3. The staggered baseline
durations show that the effects are not merely due to participating in baselines of certain durations.
Also, all treatments were initiated at different real times, so the results should not be due to a single
environmental event. Finally, the treatment was tested within each participant, thus showing replication
across participants. A final advantage to this design was that it afforded a scientifically sound way to
measure treatment impact with a relatively small sample size, and allowed all participants to receive the
active treatment without the need for control conditions.
The secondary dependent variables were collected from the Y-BOCS, OCI-R, BDI-II, SCSORF, and QOLS, to
support and verify findings from the self-monitoring. Formal pretreatment, posttreatment, and 3-month
follow-up assessment sessions occurred for each participant. All measures previously listed were
completed at all assessment points with the exception of the SCID, which was only completed at
pretreatment, and the TEI-SF, which was only completed at posttreatment. To monitor weekly progress
of the main ACT process (psychological flexibility), the AAQ-II was administered multiple times during
pretreatment (when possible), on a weekly basis from pretreatment to posttreatment, and at follow-up.
Collection of these data helps to provide some information regarding the degree and timing of
reductions in psychological inflexibility in comparison with compulsion frequency. For example, the
model of change would not be supported if reductions in symptoms were seen prior to any reductions in
psychological flexibility. Whereas, it is more supportive of the model if psychological flexibility and
compulsions decrease together or psychological flexibility decreases prior to compulsions.
Treatment
ACT for OCD (Twohig, 2009; Twohig et al., 2006; Twohig et al., 2010) was utilized in this study. The
underlying model of ACT centers around facilitating the following six core processes: (a) learning to
accept (vs. fight against) the presence of unwanted intrusive thoughts; (b) learning to defuse from or
disempower language in certain situations, including when obsessions are occurring; (c) coming to view
the self as the context within which thoughts and feelings occur versus viewing one’s self as
synonymous with the content of thoughts; (d) an emphasis on contact with the present moment or
mindfulness; (e) the identification and/or cultivation of core life values, thereby increasing motivation to
engage in treatment and life; and (f) the fostering of committed action in alignment with these values.
ACT for OCD was implemented in eight, weekly, 1 to 1.5 hour sessions.
ACT relies heavily on the use of metaphor and exercises as an interactive pedagogical device to help
foster a deeper incorporation of these core processes, along with weekly, behavior-based homework
assignments to allow greater incorporation of learned skills. All sessions following Session 1 had the
following components (and thus are not necessarily listed in Table 2): assessment of functioning, review
of components, and homework assignments. The third author served as the therapist for Participant 1
and the first author served as the therapist for all remaining participants. The first author was trained
and supervised by the third author. There were no notable differences as a result of therapist.
Integrity of Treatment Administration
All sessions were video recorded. The third author reviewed intake material, confirmed the OCD
diagnoses, and supervised Y-BOCS scores for accuracy. Twenty-five percent of all therapy sessions (10
out of 40) were rated for treatment integrity by the second author, a senior graduate assistant who has

been trained to competency in treatment integrity of ACT for OCD (Twohig et al., 2010). The coding
system for the rating was based on a previously utilized scoring system (Twohig et al., 2006). Overall
therapist competency and overall adherence to the ACT model were rated with the following scale: 1 =
not at all adherent/competent to 5 = extremely adherent/competent. Individual assessment of the six
core ACT processes, along with individual assessment of therapy actions that are less consistent or
inconsistent with ACT, were also rated. Therapy actions deemed to be less consistent or inconsistent
with ACT included discussion of cognitive content, indications that thoughts and feelings cause
behaviors, behavior management to regulate thoughts/feelings, and ERP procedures (intentionally
invoking obsessions in-session, collecting SUDS (subjective units of distress) ratings, teaching response
prevention, etc.). Values of ratings were as follows: 5 = occurred with high frequency and was covered in
a very in-depth manner, 4 = occurred with relatively high frequency and was addressed in a moderately
in-depth manner, 3 = occurred several times and was covered at least once in a moderately in-depth
manner, 2 = occurred at least once and not in an in-depth manner, and 1 = the variable was never
explicitly covered. Overall adherence to the manual and overall therapist competence were highly rated
(M = 4.0, SD = 0.8, and M = 4.3, SD = 0.7, respectively). Means for the various ACT components over the
eight sessions were as follows: acceptance, M = 3.3 (SD = 1.4); defusion, M = 2.2 (SD = 1.1); self as
context, M = 1.4 (SD = 0.7); present moment, M = 1.5 (SD = 0.7); values, M = 2.9 (SD = 1.6); and
committed action, M = 2.7 (SD = 1.2). Means for therapy actions that are less consistent or inconsistent
with ACT were as follows: discussion of content of obsessions, M = 2.0 (SD = 1.1); cognitive model, M =
1.0 (SD = 0); behavior management, M = 1.0 (SD = 0); and in-session exposure, M = 1.0 (SD = 0).
An additional scoring system was also used for this study, in an attempt to measure treatment content
on a per-minute basis. The same senior graduate student administered this scoring system. Out of a
total of 845 min of assessed therapy over eight sessions, therapy time was generally distributed as
follows (note some overlap): general assessment: 380 min (45% of total), acceptance: 212 min (25% of
total), values: 158 min (19% of total), committed action: 93 min (11% of total), defusion: 70 min (8% of
total), self-as-context: 17 min (2% of total), present moment: 14 min (2% of total), discussion of
obsessions content: 53 min (6%), and in-session exposure: 0 min (0% of total).
Results
Individual rates of self-monitored compulsions and avoided valued activities are presented for each
participant (Figures 1 and 2). Individual scores at pretreatment, posttreatment, and 3-month follow-up
are in Table 3. Group averages across all measures are presented in the text.
Figure 1. Daily frequency of compulsions (diamonds/solid line) and weekly ACT process scores
(triangles/dotted line) for the five participants in baseline and treatment phases.
Note: ACT = acceptance and commitment therapy; P = participant; AAQ-II = Acceptance and Action
Questionnaire II.
Figure 2. Daily frequency of avoided valued activities (diamonds/solid line) and weekly ACT process
scores (triangles/dotted line) for the five participants in baseline and treatment phases.
Note: ACT = acceptance and commitment therapy; P = participant; AAQ-II = Acceptance and Action
Questionnaire II.
Compulsions and Avoided Valued Activities Frequency

Participant 1. The pretreatment average for Participant 1’s daily compulsions was M = 10.0 (SD = 2.3).
Her compulsions reduced by 50% by Day 36 of treatment, further reduced to M = 1.8 (SD = 1.3) by
posttreatment, and to M = 1.6 (SD = 0.8) by follow-up. The pretreatment average for Participant 1’s daily
avoided valued activities was M = 0.8 (SD = 0.8). Her reported avoided activities were reduced to 0 by
Day 36 of treatment, and this rate was maintained through posttreatment (M = 0.0, SD = 0.0), rising
slightly at follow-up to M = 0.1 (SD = 0.4).
Participant 2. The pretreatment average for Participant 2’s daily compulsions was M = 52.1 (SD = 23.0).
His compulsions reduced by 52% by Day 66 of treatment, and reduced to M = 13.5 (SD = 4.3) by
posttreatment, and M = 8.7 (SD = 4.4) by follow-up. The pretreatment average for Participant 2’s daily
avoided valued activities was M = 3.0 (SD = 3.2). His avoided activities were reduced to 0 by Day 66 of
treatment, and this rate was maintained through posttreatment (M = 0.0, SD = 0.0) and at follow-up (M
= 0.0, SD = 0.0).
Participant 3. The pretreatment average for Participant 3’s daily compulsions was M = 5.3 (SD = 1.4). His
compulsions were reduced by 62% by Day 41, reduced to M = 2.4 (SD = 0.5) by posttreatment, and to M
= 0.5 (SD = 0.8) by follow-up. The pretreatment average for Participant 3’s daily avoided valued activities
was M = 2.2 (SD = 0.6). His avoided activities were reduced by 54% by Day 56 of treatment, reduced to
M = 0.9 (SD = 0.4) by posttreatment, and then decreased to 0 at follow-up.
Participant 4. The pretreatment average for Participant 4’s daily compulsions was M = 42.1 (SD = 14.2).
Her compulsions were reduced by 64% by Day 78 of treatment, and reduced to M = 6.6 (SD = 4.4) by
posttreatment, and M = 2.9 (SD = 0.9) by follow-up. The pretreatment average for Participant 4’s daily
avoided valued activities was M = 21.8 (SD = 7.3). Her avoided activities reduced by 77% by Day 78 of
treatment, and reduced to M = 1.7 (SD = 1.3) by posttreatment and to M = 1.6 (SD = 1.1) by follow-up.
Participant 5. The pretreatment average for Participant 5’s daily compulsions was M = 15.6 (SD = 8.1).
Her compulsions reduced by 55% by Day 66 of treatment, and reduced to M = 3.9 (SD = 1.2) by
posttreatment, but increased to M = 8.0 (SD = 1.6) by follow-up. The pretreatment average for
Participant 5’s daily avoided valued activities was M = 2.0 (SD = 1.6). Her avoided activities reduced by
51% by Day 58 of treatment, and reduced to M = 1.1 (SD = 1.1) by posttreatment, and to M = 0.9 (SD =
0.4) by follow-up.
Overall. Aggregating across all five participants, average daily compulsions were M = 25.0 (SD = 20.8) at
pretreatment, and then decreased by 74% to M = 5.6 (SD = 4.8) at posttreatment, and by 80% to M = 4.3
(SD = 3.8) at follow-up. Average daily avoided valued activities were M = 6.0 (SD = 8.9) at pretreatment,
and then decreased by 79% to M = 0.7 (SD = 0.7) at posttreatment, and by 87% to M = 0.5 (SD = 0.7) at
follow-up.
OCD Measures
Average Y-BOCS scores were M = 25.4 (SD = 5.6) at pretreatment, and decreased by 51% to M = 12.4 (SD
= 5.1) at posttreatment, and by 54% to M = 11.8 (SD = 2.9) at follow-up. OCI-R scores followed a similar
trend, measuring M = 31.8 (SD = 12.3) at pretreatment, decreasing by 55% to M = 14.4 (SD = 4.7) at
posttreatment, and rising slightly to M = 16.4 (SD = 7.5) at follow-up, for a pretreatment to follow-up
reduction of 48%. Scrupulosity symptom severity mean scores (as measured by the PIOS) began at M =
54.6 (SD = 10.7) at pretreatment, decreasing by 50% to M = 27.2 (SD = 3.8) at posttreatment, staying

relatively constant at M = 26.8 (SD = 8.4) during follow-up. OCD measure subscores were consistent with
total scores and are available from corresponding authors.
Religious Faith
Notably, while scrupulosity-based OCD declined, religious faith (as measured by the SCSORF) declined
only 4% from pretreatment (M = 29.2, SD = 2.7) to posttreatment (M = 28.0, SD = 4.6), and 7% from
pretreatment to follow-up (M = 27.3, SD = 4.5).
Depression
Depression symptom severity as measured by the BDI-II was M = 30.6 (SD = 15.2) at pretreatment,
decreasing by 73% to M = 8.4 (SD = 3.2) at posttreatment, rising slightly to M = 10.2 (SD = 4.7) at followup for a final pretreatment to follow-up reduction of 67%.
Quality of Life
Quality-of-life scores (as measured by the QOLS) began at M = 60.6 (SD = 15.7) at pretreatment, rising by
26% to M = 76.6 (SD = 7.7) at posttreatment, rising slightly again to M = 77.8 (SD = 10.5) during followup for a final pretreatment to follow-up increase of 28%.
Psychological Processes of Change
Psychological process change as measured by the AAQ-II seemed to occur across the participants as
expected (Figures 1 and 2). The mean score on the AAQ-II across all participants was M = 36.2 (SD = 5.2)
at pretreatment, declining by 40% to M = 21.6 (SD = 4.8) at posttreatment, declining further to M = 20.6
(SD = 8.4) at follow-up for a final pretreatment to follow-up decrease of 43%. When graphed, declining
AAQ-II slopes appear to generally co-occur with declines in both compulsions and avoided valued
activities.
Treatment Acceptability
ACT was found to be highly acceptable by all participants, with a mean score of 30 on the TEI-SF at
posttreatment, only 5 points below the maximum score of 35 (or 86% of the maximum score).
Discussion
In this study, five participants diagnosed with scrupulosity-based OCD received eight sessions of ACT in a
multiple baseline across participants design. At posttreatment, participants reported a 74% reduction in
self-reported compulsions and a 79% reduction in avoided valued behaviors, and at 3-month follow-up
participants reported an 80% reduction in compulsions and an 87% reduction in avoided valued
behaviors. At posttreatment, participants averaged notable decreases in Y-BOCS (51%), OCI-R (55%),
PIOS (50%), and BDI-II (73%) scores, and an increase in QOLS (26%) scores. These results were generally
maintained at 3-month follow-up. Finally, whereas scrupulous symptom severity declined considerably,
religious faith (as measured by the SCSORF) declined only 4% from pretreatment to posttreatment and
7% from pretreatment to follow-up, indicating that the reduction in compulsive religious behavior was
not associated with notable changes in faith. Arguably, the reductions seen on the SCSORF could be
associated with reductions in compulsive religious or moral behavior.

The primary process of change measure for this study was the AAQ-II (self-report), which measures the
main psychological processes targeted in ACT such as acceptance, defusion, values, and so on. From
pretreatment to posttreatment, AAQ-II scores decreased by 40%, which was maintained at follow-up
(43%). Based on a visual assessment of outcome and process data graphed together, it appears as
though process change correlated consistently with compulsion and avoided activities behavior change
across four out of five participants (Participant 5 being a possible exception). It is theorized that
Participant 5’s lack of process change correlation might be due to a set of uncharacteristically disruptive
life events that occurred toward the end of her course of treatment. In terms of treatment acceptability,
ACT was found to be highly acceptable by all five participants, averaging a mean score of 30 on the TEISF at posttreatment, which is only 5 points below the maximum score of 35 (or 86%).
The bulk of current OCD research continues to center on either pharmaceutical interventions or ERP.
While the past few years have produced a slight uptick in research about ACT for OCD, a considerable
amount of work remains for ACT and its role in the treatment of OCD (Tolin, 2009). This study lends
further credence to the utility of ACT as a treatment option for OCD. With regard to scrupulosity-based
OCD specifically, this study represents the only known psychological treatment outcome study to be
conducted exclusively for religious or moral-based OCD. Given the favorable results of the study,
additional ACT for scrupulosity-based OCD research is warranted. On one hand, ACT for OCD work can
continue as a stand-alone treatment. On the other hand, exposure exercises can fit nicely into the ACT
model and can provide great opportunities to practice ACT techniques in session. In addition, exposure
exercises can occur outside of session as long as the client focuses on enhancing ACT processes during
the exercises. This generally involves a greater focus on acceptance and mindfulness during the
exercises, and linking the exercises to one’s values. Research will show the utility of ACT alone, or ACT
and exposure exercises together, for the treatment of OCD generally and scrupulosity-based OCD
specifically.
The results of this study show promise that the use of ACT in the treatment of scrupulosity-based OCD
might be of particular utility because of the following: (a) ACT appears to be rated as highly acceptable
to scrupulosity clients, potentially leading to low refusal, drop-out, and nonresponse rates (Twohig et al.,
2010); (b) ACT is metacognitive and does not need to address religious content, and thus, potentially
avoiding therapist need to navigate specific religious doctrines or to interact with the client’s
ecclesiastical leaders to ensure ethical or effective treatment; and (c) ACT appears to achieve favorable
results with scrupulosity in a very short period of time (12 therapy hours per client in this study).
There are several limitations to this study. As a preliminary study, it utilized a small number of
participants (five). In addition, the SCID and Y-BOCS assessments were conducted by the same individual
who served as the primary therapist (under supervision), although other measures relied on self-report.
Though suboptimal, this combination of a small N, assessor administered, and self-report design is a
broad, standardly used, and useful combination of outcome assessment procedures (Twohig & Crosby,
2010; Twohig et al., 2006). Self-monitoring is relied upon for both of the primary dependent variables in
this study, and while considered to be a valuable tool for treatment monitoring, self-monitoring can also
have modest reactive effects, often in the therapeutically desired direction (Korotitsch & Nelson-Gray,
1999). While such reactive effects are certainly plausible, it should be noted that the findings for the
main dependent variables were supported by multiple additional standardized measures (OCI-R, PIOS)
as well as by a therapist-administered measure (Y-BOCS). In addition, the Twohig et al. (2010) study of
ACT for OCD did not include self-monitoring and achieved strong results. Nevertheless, there may be

clinical utility to self-monitoring and ACT over ACT alone for scrupulosity-type OCD, as self-monitoring
may help raise awareness of one’s symptoms. This will have to be evaluated in future research.
Because most of the compulsions reported in this study were covert or private, all of the participants
reported difficulty quantifying their daily compulsions. This led to considerable anxiety (and potentially
increased levels of compulsions) for many of the participants, and was particularly burdensome for
scrupulous clients, given their frequent drives for moral integrity/honesty. To illustrate, one participant
withdrew from the study prior to treatment, citing the excessive burden of counting compulsions as the
main concern. Interestingly, another participant withdrew from the study prior to treatment noting that
the act of tracking compulsions made him more aware of his behavior, leading to a decrease in his
perceived symptom severity.
Regarding treatment, only eight sessions were administered per participant. It is possible that the
participants would have achieved additional gains if more sessions were offered. Also, as noted through
the treatment integrity scoring, while the therapists were rated a 4 out of 5 on ACT compliance, the
therapists occasionally engaged in discussions regarding cognitive (e.g., religious) content, which is of
questionable compliance with the ACT model. All five of the participants were Caucasian members of
the Church of Jesus Christ of Latter-Day Saints with relatively high education levels, all of which could
feasibly impact generalizability. Finally, a more extended follow-up (6 or 12 months) would likely provide
more useful outcome data than 3 months. In conclusion, it appears as though ACT shows considerable
promise as a treatment for scrupulosity-based OCD, and that further research is warranted.
Authors’ Note
This study was completed as John Dehlin’s master’s thesis equivalent at Utah State University. A copy of
the manual is available from the corresponding author.
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or
publication of this article.
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this
article.
References
Abramowitz J. S. (2001). Treatment of scrupulous obsessions and compulsions using exposure and
response prevention: A case report. Cognitive and Behavioral Practice, 8, 79-85. Crossref
Abramowitz J. S. (2008). Scrupulosity. In Abramowitz J., McKay D., Taylor S. (Eds.), Clinical handbook of
obsessive-compulsive disorder and related problems (pp. 157-172). Baltimore, MD: Johns Hopkins
University Press.
Abramowitz J. S., Huppert J. D., Cohen A. B., Tolin D. F., Cahill S. P. (2002). Religious obsessions and
compulsions in a non-clinical sample: The Penn Inventory of Scrupulosity (PIOS). Behaviour Research and
Therapy, 40, 824-838. Crossref

American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.).
Washington, DC: Author.
Beck A. T. (1996). Beck Depression Inventory (2nd ed.). San Antonio, TX: The Psychological Corporation.
Beck A. T., Epstein N., Brown G., Steer R. A. (1988). An inventory for measuring clinical anxiety:
Psychometric properties. Journal of Consulting and Clinical Psychology, 56, 893-897. Crossref PubMed.
Bonchek A., Greenberg D. (2009). Compulsive prayer and its management. Journal of Clinical
Psychology, 65, 396-405. Crossref PubMed.
Bond F. W., Hayes S. C., Baer R. A., Carpenter K. M., Guenole N., Orcutt H. K., Zettle R. D. (2011).
Preliminary psychometric properties of the Acceptance and Action Questionniare—II: A revised measure
of psychological inflexibility and experiential avoidance. Behavior Therapy, 42, 676-688. Crossref
PubMed.
Burckhardt C. S., Woods S. L., Schultz A. A., Ziebarth D. M. (1989). Quality of life of adults with chronic
illness: A psychometric study. Research in Nursing & Health, 12, 347-354. Crossref PubMed.
Cefalu P. (2010). The doubting disease: Religious scrupulosity and obsessive-compulsive disorder in
historical context. Journal of Medical Humanities, 31, 111-125. Crossref PubMed.
Ciarrocchi J. W. (1995). The doubting disease: Help for scrupulosity and religious compulsions. New York,
NY: Paulist.
Fallon B. A., Liebowitz M. R., Hollander E., Schneier F. R. (1990). The pharmacotherapy of moral or
religious scrupulosity. Journal of Clinical Psychiatry, 51, 517-521. PubMed.
First M. B., Spitzer R. L., Gibbon M., Williams J. B. W. (2002). Structured Clinical Interview for DSM-IV-TR
Axis I Disorders, Research Version, Patient Edition (SCID-I/P). New York: Biometrics Research, New York
State Psychiatric Institute.
Foa E. B., Huppert J. D., Leiberg S., Langner R., Kichic R., Hajcak G., Salkovskis P. M. (2002). The
Obsessive–Compulsive Inventory: Development and validation of a short version. Psychological
Assessment, 14, 485-496. Crossref PubMed.
Garcia H. A. (2008). Targeting Catholic rituals as symptoms of obsessive compulsive disorder: A
cognitive-behavioral and psychodynamic, assimilative integrationist approach. Pragmatic Case Studies in
Psychotherapy, 4(2), 1-38. Crossref.
Goodman W. K., Price L. H., Rasmussen S. A., Mazure C. (1989a). The Yale-Brown Obsessive Compulsive
Scale: I. Development, use, and reliability. Archives of General Psychiatry, 46, 1006-1011. Crossref
PubMed.
Goodman W. K., Price L. H., Rasmussen S. A., Mazure C. (1989b). The Yale–Brown Obsessive Compulsive
Scale: II. Validity. Archives of General Psychiatry, 46, 1012-1016. Crossref PubMed.
Greenberg D., Witztum E. (2001). Treatment of strictly religious patients. In Pato M. T., Zohar J. (Eds.),
Current treatments of obsessive-compulsive disorder (2nd ed., pp. 173-191). Washington, DC: American
Psychiatric Association.

Hayes S. C., Strosahl K. D., Wilson K. G. (1999). Acceptance and commitment therapy: An experiential
approach to behavior change. New York, NY: Guilford.
Huppert J. D., Siev J. (2010). Treating scrupulosity in religious individuals using cognitive-behavioral
therapy. Cognitive and Behavioral Practice, 17, 382–392. Crossref
Jackson J. L. (1999). Psychometric considerations in self-monitoring assessment. Psychological
Assessment, 11, 439-447. Crossref
Jacobson N. S., Truax P. (1991). Clinical significance: A statistical approach to defining meaningful change
in psychotherapy research. Journal of Consulting and Clinical Psychology, 59, 12-19. Crossref PubMed.
Kelley M. L., Heffer R. W., Gresham F. M., Elliott S. N. (1989). Development of a modified treatment
evaluation inventory. Journal of Psychopathology and Behavioral Assessment, 11, 235-247. Crossref
Korotitsch W. J., Nelson-Gray R. O. (1999). An overview of self-monitoring research in assessment and
treatment. Psychological Assessment, 11, 415-425. Crossref
Meuret A. E., Twohig M. P., Hayes S. C., Rosenfield D., Craske M. G. (2012). Brief acceptance and
commitment therapy and exposure for panic disorder: A pilot study. Cognitive and Behavioral Practice,
19, 606-618. Crossref
Miller C. H., Hedges D. W. (2008). Scrupulosity disorder: An overview and introductory analysis. Journal
of Anxiety Disorders, 22, 1042-1058. Crossref PubMed.
Plante T. G., Boccaccini M. T. (1997). The Santa Clara Strength of Religious Faith Questionnaire. Pastoral
Psychology, 45, 375-387. Crossref
Segal D. L., Hersen M., Van Hasselt V. B. (1994). Reliability of the Structured Clinical Interview for DSMIII–R: An evaluative review. Comprehensive Psychiatry, 35, 316-327. Crossref PubMed.
Tolin D. F. (2009). Alphabet soup: ERP, CT, and ACT for OCD. Cognitive and Behavioral Practice, 16, 4048. Crossref
Twohig M. P. (2009). The application of acceptance and commitment therapy to obsessive-compulsive
disorder. Cognitive and Behavioral Practice, 16, 18-28. Crossref
Twohig M. P., Crosby J. M. (2010). Acceptance and commitment therapy as a treatment for problematic
Internet pornography viewing. Behavior Therapy, 41, 285-295. Crossref PubMed.
Twohig M. P., Hayes S. C., Masuda A. (2006). Increasing willingness to experience obsessions:
Acceptance and commitment therapy as a treatment for obsessive compulsive disorder. Behavior
Therapy, 37, 3-13. Crossref PubMed.
Twohig M. P., Hayes S. C., Plumb J. C., Pruitt L. D., Collins A. B., Hazlett-Stevens H., Woidneck M. R.
(2010). A randomized clinical trial of acceptance and commitment therapy vs. progressive relaxation
training for obsessive compulsive disorder. Journal of Consulting and Clinical Psychology, 78, 705-716.
Crossref PubMed.
Author Biographies

John P. Dehlin, MS, is a doctoral student in psychology at Utah State University. His research focuses on
the nexus of religion and mental health.
Kate L. Morrison, BA, is a doctoral student in psychology at Utah State University. Her research and
clinical interests are in ACT, delay discounting, and treatment of anxiety disorders.
Michael P. Twohig, PhD, is an associate professor of Psychology at Utah State University. His research
focuses on the treatment of anxiety disorders using exposure-based therapies and acceptance and
commitment therapy.

